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Abstract
Background: While the health risks of using ecstasy warrant intervention development, a recent
meta-analysis of determinants of ecstasy use identified a number of lacunae in the literature.
Specifically, no studies were included that address behaviours other than 'using ecstasy' (e.g. 'trying
out ecstasy' or 'ceasing ecstasy use'). However, because meta-analyses aim to integrate study
results quantitatively, the resulting rigid exclusion criteria cause many studies to be discarded on
the basis of their qualitative methodology. Such qualitative studies may nonetheless provide
valuable insights to guide future research. To provide an overview of these insights regarding
ecstasy use, the current study summarizes and combines what is known from qualitative and
exploratory quantitative literature on ecstasy use.
Methods:  The databases PsycINFO and MedLine were searched for publications reporting
reasons for ecstasy use and related behaviour, and the results were structured and discussed per
behaviour and compared over behaviours.
Results: Two main categories of reasons were found. The first category comprised reasons to
start using ecstasy, use ecstasy, use ecstasy more often, and refrain from ceasing ecstasy use. The
second category comprised reasons to refrain from starting to use ecstasy, use less ecstasy, and
cease using ecstasy. Reasons for related behaviours within each of these two categories appear to
differ, but not as substantially as between the two categories. A large number of reasons that were
not yet explored in quantitative research emerged.
Conclusion: The current summary and combination of exploratory studies yields useful lists of
reasons for each behaviour. Before these lists can inform interventions, however, they beg
quantitative verification. Also, similarity of determinant configurations of different behaviours can
be assessed by addressing determinants of several behaviours in one study. Another important
finding is that meta-analytical integration of the literature may overlook important findings and
implications. Thus, qualitative reviews remain useful instruments in setting the research agenda.
Background
Although evidence that ecstasy use may be damaging to
health accumulates [1,2], its prevalence persists [3,4]. The-
ory-based behavioural interventions have successfully
generated behaviour change in other areas [5,6], and may
likewise have beneficial effects when applied to ecstasy
use. However, development of an effective intervention
requires knowledge about which modifiable determi-
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nants need to be targeted [7]. A recent meta-analysis of
quantitative studies on ecstasy use and related behaviours,
which aimed to provide this knowledge, concluded that
much research is still necessary [8]. Specifically, of all
behaviours relevant to ecstasy use (e.g. trying out ecstasy,
applying harm reduction strategies, ceasing ecstasy use)
only the broad behavioural category of 'using ecstasy' had
been addressed by the included studies. Because meta-
analyses aim to quantitatively integrate the literature, they
generally exclude studies that do not report certain statis-
tics. For example, the meta-analysis about ecstasy use
included only studies that "assess quantitatively the rela-
tionship between determinants and behaviour or inten-
tion" [[8], p. 110]. These restrictive inclusion criteria led
to the exclusion of all qualitative and exploratory studies
into the reasons for ecstasy use, while paradoxically, it is
exactly this exploratory methodology that renders these
studies particularly valuable in setting the research
agenda. The current review sets out to inform future
research into ecstasy use and related behaviours by sum-
marising this qualitative and exploratory quantitative lit-
erature.
Although the aforementioned meta-analysis did result in
a list of determinants that seem relevant for ecstasy use
(i.e. attitude, subjective norm, perceived behavioural con-
trol, moral norm, anticipated regret and habit), consider-
ation of the most salient underlying beliefs indicated that
some of these determinants of ecstasy use may prove
exceptionally hard to modify [8]. For example, although
ecstasy users had a higher descriptive norm than non-
users (i.e. users perceived there to be more ecstasy use at
dance events), this difference appeared to reflect an under-
estimation of actual ecstasy use prevalence on the part of
non-users. In this case, therefore, correcting this errone-
ous belief would lead to more ecstasy use, and an interven-
tion aiming to decrease descriptive norms among ecstasy
users would have to present incorrect information about
the prevalence of ecstasy use (i.e. portray ecstasy use prev-
alence as lower than it is). The difficulties of intervening
on the reported determinants seem to be underlined by a
recent evaluation of an intervention among ecstasy users,
where the authors concluded that a brief motivational
intervention was no more efficient than the information-
only control condition [though use decreased in both
conditions, which most control participants attributed to
the self-assessment at baseline; [9]]. In addition, none of
the reviewed studies specifically addressed the initiation
or cessation of ecstasy use or the application of harm
reduction strategies. All studies addressed the broad
behavioural category of 'using ecstasy' [e.g. by comparing
users with non-users, or examining the intention to 'use
ecstasy'; [8]], which may be problematic because determi-
nants of related but different behaviours such as these are
assumed to differ [7,10]. Finally, it seemed that the sum-
marized research had not addressed a number of poten-
tially relevant determinants [8].
Thus, so far, only one of several relevant behaviours has
been reviewed; the identified determinants appear hard to
modify; and relevant determinants may have been omit-
ted. The current paper investigates whether studies into
other ecstasy use-related behaviours or addressing other
determinants do exist, but were excluded by the rigid
exclusion criteria of the meta-analysis drawing these con-
clusions. Specifically, the current paper reports a struc-
tured review of all qualitative studies and exploratory
studies, which did not report an association with inten-
tion or behaviour but did report reasons for performing
(or not performing) an ecstasy use-related behaviour (e.g.
trying out ecstasy, ceasing ecstasy use, getting ecstasy
tested, or drinking water during use). The aim of this over-
view is to guide further quantitative research into ecstasy
use, eventually enabling development of effective evi-
dence-based interventions.
Methods
Relevant literature was identified through the databases
PsycINFO and MedLine. These were accessed through the
Ovid SilverPlatter WebSpirs interface (version 5.12). At
the 21st  of August 2008, the query "(("ecstasy" OR
"mdma" OR "xtc" OR "methyldioxymethamphetamine"
OR "party drug" OR "party drugs" OR "club drug" OR
"club drugs" OR "dance drug" OR "dance drugs") IN TI,
AB) AND (LA = "English")" was entered, which searched
for all English records that contain ecstasy (or a synonym)
in their title or abstract. This query yielded 4574 hits
(1232 from PsycINFO and 2021 from MedLine). The
phrase "NOT ("mouse" OR "mice" OR "rat" OR "rats")"
was added, which eliminated 1321 hits. The remaining
3253 entries were downloaded and imported into a refer-
ence management program [11], which automatically
identified and deleted 741 duplicates (defined as entries
with the same title and year of publication). The titles and
abstracts of the 2512 remaining records were manually
inspected for relevance, and all publications reporting rea-
sons for an ecstasy use-related behaviour were acquired.
The acquired publications were examined in more detail,
and if upon closer inspection a paper turned out to not
report any reasons for ecstasy use or a related behaviour,
it was excluded accordingly. In total, 2490 publications
were excluded.
Most excluded records described biological studies [e.g.
[12,13]], followed by a large number of publications
describing prevalence of drug use, sometimes combined
with demographic variables [e.g. [14,15]]. A number of
studies also investigated consequences, perceived effects,
or risks of ecstasy use [e.g. [16,17]]. Unless these were
reported in response to a question about reasons, or con-BMC Public Health 2009, 9:230 http://www.biomedcentral.com/1471-2458/9/230
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sidered as reasons by the author of the original paper,
these were not considered as reasons in the current paper
either. Also, studies not reporting original empirical data
were excluded [e.g., discussions or reviews, see for exam-
ple [18,19]]. Finally, studies that did not investigate the
target population (i.e. young recreational ecstasy users in
western society) were excluded [e.g. [20,21]], as it has
been shown that factors influencing behaviour can differ
between populations [22-24].
Results
Included studies
Details of the included 22 publications [25-46] are pro-
vided in Table 1. The included studies examined several
behaviours, and given the qualitative or exploratory quan-
titative nature of these data, this renders presentation of
all results challenging. In 2006, Baylen and Rosenberg
[47] reported a review with a goal similar to the current
goal, and with resulting data that were structured simi-
larly. As the way in which they report their results seems
very useful for the current purposes, this approach will
roughly be followed. Specifically, we will report the per-
centages that were reported in each study in a table,
grouped by reason category (rows) and behaviour (col-
umns). Two groups of behaviours share a number of rea-
sons, and the results pertaining to these groups of
behaviours are therefore presented in the same table.
Table 2 contains four "more-use behaviours": behaviours
leading to consumption of more ecstasy (starting use,
"using ecstasy" in general, using more ecstasy, and not
ceasing ecstasy use). Table 3 contains three "less-use
behaviours": behaviours leading to consumption of less
ecstasy (not starting use, using less ecstasy, or ceasing use).
In addition to these seven behaviours, a number of studies
addressed reasons for combining ecstasy with other drugs
and applying harm reduction strategies
[25,28,29,35,36,40,46]. Because of the multitude of dif-
ferent behaviours, these reasons will not be tabulated but
rather discussed in the text.
The authors have clustered the reasons in Tables 2 and 3,
but exclusively to ease presentation and discussion, as the
qualitative nature of this review prohibits quantitative
integration of the results. These categories were estab-
lished by first entering all reasons into an online database
[where they are available to the interested reader; see
[48]]. Then, the first author clustered those reasons that
appeared similar, eventually reaching a list of relatively
distinct categories. The clustering does not suggest that the
grouped reasons are psychologically similar, but rather
only serves to ease presentation and discussion of the
results. Therefore, the original descriptions for each rea-
son are listed in the first column of every table. In addi-
tion, interested readers can consult the original
(unclustered) lists of reasons, which have been made pub-
licly available [48]. The descriptions are provided in the
same order as the corresponding reporting frequency (if
available). When several reasons within one category were
extracted from one study, the descriptions and reporting
frequencies are separated by commas.
More-use behaviours
A number of patterns emerge when all studies into start-
ing use, "using ecstasy" in general, using more ecstasy, and
not ceasing ecstasy use are combined (see Table 2). First,
like studies in the meta-analysis, most currently reviewed
studies focused on the behaviour 'using ecstasy'. However,
there is still a lot of data on other behaviours, such as start-
ing to use ecstasy, using more ecstasy, and not ceasing
ecstasy use. The reason categories in which the reasons for
these behaviours fall have been summarised in Table 4. In
this table, a tentative attempt has been made to indicate
each reason category's relevance, based on the frequency
with which the reasons in a category were endorsed by
participants. When at least one reason in a reason category
was endorsed by more than half of the participants, a rea-
son category was considered very relevant (indicated in
the table by '+'); when reasons in a reason category were
reported by less than half, but more than one in ten par-
ticipants, a reason category was considered moderately
relevant ('±'); and when reasons in a reason category were
reported by one in ten participants or less, the category
was considered minimally relevant ('-'). When no fre-
quency information was available (i.e. with interview
studies where only quotes were provided), the symbol 'N'
is used, and in the one case where the only study sug-
gested that a reason was irrelevant, the symbol '8' is used.
Three reasons from Table 2, specifically fear of health
risks, noticing mood/affective/cognitive changes in one-
self, and one's own or another's bad experience, were each
reported as reasons for using more ecstasy by 1% of the
participants of study F [46]. The current authors assumed
that this reflects measurement error, and upon being con-
tacted, the original authors confirmed that they share this
assumption. These reasons have therefore been omitted
from Table 4.
When this information is combined for all more-use
behaviours, it becomes clear that although some reason
categories are equally relevant for all behaviours, there are
also differences. Understandably, curiosity only seems rel-
evant for starting ecstasy use; denial of negative effects
only seems relevant for not ceasing use; and tolerance is
only relevant for using more ecstasy. However, other dif-
ferences are less intuitive. For example, social influence,
and ecstasy's ability to provide energy and enhance social
interaction and sensory perception, do not seem to play a
big role in starting to use ecstasy.BMC Public Health 2009, 9:230 http://www.biomedcentral.com/1471-2458/9/230
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Table 1: Authors and publication years of the included studies, and the letter denoting these studies.
Authors and number in 
reference list
Year l* Country Time Sampling 
method
Measurement N %  Age
Solowij, Hall & Lee [40] 1992 A Australia NR RDS Questionnaire 100 39% 27
Fountain, Bartlett, Griffiths, Gossop, 
Boys & Strang [32]
1999 B UK NR Selected sample 
with diverse 
experience with 
drugs
Interview 100 36% 18
Topp, Hando, Dillon, Roche & 
Solowij [43]
1999 C Australia NR RDS, 
advertisement, 
radio, flyers
Interviews 329 51% 23
Boys, Marsden & Strang [27] 2001 D UK August-
November 
1998
RDS Questionnaire 364 44% 19
Hansen [35] 2001 E Australia July 1998-
February 2000
Explicit selection Participant 
observation & 
interviews
31 42% 25
Winstock, Griffiths & Stewart [46] 2001 F UK June 1999 Questionnaire in 
magazine
Questionnaire 1151 40% 24
Dundes [30] 2003 G US October 2000 Distribution by 
students
Questionnaire 719 55% 20
Fendrich, Wislar, Johnson & Hubbell 
[31]
2003 H US June 2001-
January 2002
Random selection Audio 
Computer self-
interview
627 61% 28
Verheyden, Henry & Curran [44] 2003 I UK NR Sampling in bars, 
private residences, 
clubs, universities, 
offices
Questionnaire 
guided interview
430 45% 24
Verheyden, Maidment & Curran [45] 2003 J UK NR Sampling of ex-
users from other 
study
Questionnaire 47 0% 30
Carlson, Falck, McCaughan & Siegal 
[28]
2004 K US Spring 2001-
Winter 2002
Convenience 
sample, RDS
Focus groups & 
interviews
30 50% 22
Gourley [34] 2004 L Australia NR Explicit selection Interviews & 
observations
12 50% 21
Riley & Hayward [37] 2004 M UK February-
March 2001
Sampling at dance 
venues
Questionnaire 124 50% 25
Gamma, Jerome, Liechti & Sumnall 
[33]
2005 N US** NR Links at websites Online survey 923 NR 19
Levy, O'Grady, Wish & Arria [36] 2005 O US 2003 Flyers Focus groups 30 57% 20
Soellner [39] 2005 P Germany 1994–1998 Random sample Computer 
assisted 
interviews
2246 NR NR
Allott & Redman [25] 2006 Q Australia June-December 
2004
Convenience 
sample, RDS, 
advertisement
Questionnaire 116 51% 27
Copeland, Dillon & Gascoigne [29] 2006 R Australia NR NR Interviews 216 47% 26
Rodgers, Buchanan, Pearson, 
Parrott, Ling, Hefferman & Scholey 
[38]
2006 S US, EUR** NR Links on websites Online 
questionnaire
209 40% 16–20
Sumnall, Cole & Jerome [42] 2006 T US, UK, Australia, 
Eire**
NR RDS, printed 
posters, 
advertisement, key 
informant access
Questionnaire 268 37% 26
Sterk, Theall & Elison [41] 2007 U US NR Respondent driven 
sampling
Computer 
assisted 
interviews
261 30% 21
Bellis, Hughes, Calafat, Juan, Ramon, 
Rodriguez, Mendes, Schnitzer & 
Phillips-Howard [26]
2008 V Portugal, Spain, Italy, 
Greece, Slovenia, 
Czech Republic, 
Austria, Germany, 
UK
NR RDS Questionnaire 146 49% 21
* = letter used in Tables 2 and 3 to refer to this study, ** = probably primarily these region(s) (internet study), US = United States, UK = United 
Kingdom, EUR = Europe, RDS = respondent driven sampling (e.g. snowballing), NR = not reportedBMC Public Health 2009, 9:230 http://www.biomedcentral.com/1471-2458/9/230
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Less-use behaviours
When looking at behaviours that health promoters would
generally construe as the desirable behaviours, it is clear
that most research focussed on using less ecstasy and ceas-
ing ecstasy use (see Table 3). Although the reasons for
using less ecstasy and ceasing ecstasy use were quite simi-
lar, different reasons were reported for not starting ecstasy
(see Table 4). For example, the cost of ecstasy does not
deter potential users, but it does cause users to use less or
even cease use, and other people's bad experiences can be
a reason to use less ecstasy or cease altogether, but was not
reported as a deterrent by non-users. Fearing or minimis-
ing health risks was reported for all three behaviours,
although markedly less frequently as a deterrent to not
start using ecstasy. When comparing these reasons with
the 'more-use behaviours', it became clear that there was
very little overlap. It seems that people have different rea-
sons for starting ecstasy use and for not starting ecstasy
use, and yet different reasons for using less ecstasy and for
ceasing ecstasy use, and yet again for using ecstasy.
Combining drugs and applying harm reduction strategies
In total, seven studies reported reasons to combine ecstasy
with other drugs, to apply harm reduction strategies, or to
refrain from these behaviours. Five studies reported rea-
sons to combine ecstasy with other drugs, and all reasons
fell in one of two categories [29,35,36,40,46]: to enhance
the ecstasy experience, or to minimize the comedown. To
enhance the ecstasy experience, ecstasy was combined
with ADHD medication, amphetamine, benzodiazepines,
ketamine, LSD, marijuana, and Viagra (studies A [40], E
[35], O [36] and R [29]). To minimize the comedown,
ecstasy was combined with alcohol, antihistamine, ben-
zodiazepines, cocaine, heroin, ketamine, marijuana, oxy-
codone-containing analgesics, rohypnol and valium
(studies A [40], E [35], F [46], O [36] and R [29]). Inter-
estingly, studies also reported that people refrained from
combining with other drugs to maximize the ecstasy expe-
rience (studies A [40] and K [28]). Other reasons to refrain
from combining were to minimize health risks (studies E
[35] and K [28]) and after having heard about people
dying from ecstasy use (study K [28]). To minimize health
risks, participants also pre- or postloaded with vitamins,
5-Hydroxytryptophan (5-HTP), or selective serotonin re-
uptake inhibitors (SSRIs; studies O [36], Q [25] and R
[29]). Preloading was also reported to enhance the ecstasy
experience (studies Q [25] and R [29]), and postloading
to minimize the comedown (studies Q [25] and R [29]),
and one study reported that participants drank water dur-
ing use to minimize the comedown (study Q [25]).
Most other harm reduction strategies were applied to min-
imize the potential for negative or adverse outcomes or
health risks, namely drinking water and chilling out dur-
ing ecstasy use (both from study Q [25]; chilling out
means taking breaks from dancing), purchasing fewer
ecstasy pills per occasion and limiting one's supply, only
using when in a positive mood and with friends, and the
more altruistic behaviours of guiding initiates and moni-
toring others (all from study E [35]). Then, a number of
behaviours served to deal with the uncertain contents of
ecstasy pills: using only after someone else had tried the
ecstasy (study E [35]), obtaining pills from a reliable
source (studies K [28] and O [36]), and purchasing pills in
bulk (study E [35]). However, one study also reported that
participants could avoid getting their ecstasy tested
because they considered the uncertainty (as to the pill
contents) 'part of the process' (study E [35]). Finally, one
study reported a user who liked to drive under the influ-
ence of ecstasy because he enjoyed the experience (study
E [35]).
Discussion
The papers included in this review contain valuable infor-
mation. Compared to the synthesis of quantitative litera-
ture [8], the studies included here have indeed addressed
more behaviours and more potential determinants.
Though a minority of reasons reported here has already
been quantitatively studied, those quantitative studies
have only examined their relevance for the behaviour
'using ecstasy', and the results show that reasons for differ-
ent behaviours (e.g. 'using ecstasy' and starting or ceasing
ecstasy use) differ. This means that an intervention target-
ing the important determinants for 'using ecstasy' may be
unable to effectively influence other behaviours (such as
starting or ceasing ecstasy use). This also means that devel-
opment of evidence-based interventions addressing these
other behaviours first requires studies that map the deter-
minant configurations for those specific behaviours.
Unfortunately, this review cannot inform intervention
development, because this review only provides an over-
view of how frequently a reason was reported, and com-
parison of the frequency with which reasons were
reported with the effect sizes found in the meta-analysis
for the behaviour 'using ecstasy' showed that frequently
reported reasons can correspond to beliefs that were not
associated to frequency of use (i.e. beliefs held equally
strongly by users and abstainers or by heavy users and
light users). For example, in this review, using to 'enhance
energy and dancing' was mentioned as a reason for using
ecstasy by between 39% and 91%, yet in the meta-analysis
[8], the belief that ecstasy helps to stay awake was associ-
ated to ecstasy use with a trivial effect size (i.e. Cohen's d
< .2 [49]). A second limitation of this review is the fact
that with two exceptions [26,39] all included studies have
been performed in the US, the UK and Australia. It
remains to be seen whether these conclusions apply to
other countries such as the Netherlands. Third, following
from the qualitative methodology, no conclusions can beB
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Table 2: Reasons and reported frequencies in each included study for starting ecstasy use, using ecstasy, using more ecstasy, and not ceasing ecstasy use.
Reason categories (reasons as reported in original 
papers in parentheses)
Starting ecstasy use Using ecstasy Using more ecstasy Not ceasing ecstasy use
Availability/price/quality of ecstasy
(being offered an ecstasy pill, lower cost of ecstasyE; ecstasy 
quality... decreased, increasedF; I have more money to 
spendI; availability of ecstasyM; availability ('was there so I 
tried it')O; friend offered and felt I could not declineU)
NNO NNE; 27%U NNE; 21%, 35%F; 7%I; NNM
Changing life circumstances 
(moving in or out of a certain lifestyle)
(it is part of my lifestyleI)
14%I
Curiosity
(out of curiosity, for experimental reasonsA; curious about 
good experiences of others, general interest in effects of 
psychoactive substancesK; the hype surrounding ecstasyL; 
curiosityO)
NN, NNA; NN, NNK; NNL; 
NNO
Decreased drug effects (e.g. tolerance) or decreased 
appreciation of drug effects
(needing to take more tablets than used toF; I need to take 
more to get the same effectsI; increased toleranceK)
35%F; 9%I; NNK
Denying or forgetting negative effects
(thinking "that won't happen to me" or "well, everybody else 
is doing ecstasy, and they're not having any problems", upon 
hearing about negative consequencesK; unpleasant 
experiences are forgotten and the excitement of going out 
and socialising takes overL)
NNK; NNL
Desire to be on the same level as friends (i.e. to be 
intoxicated in the same way)
(to get into the spirit of the partyH; it makes you sad if you're 
at a club and you see everybody else is having all this fun and 
you're notK; having a shared experience, desire to be on the 
same level as friendsL; social pressure ("you see friends 
having a great time and you want to join")O
NNK; NNO 70%H; NN, NNL
Ease of administration
(controlled freedom/sense of control, provides fun, 
confidence and companionship that users seek without 
negative consequences associated with other drugs, effects 
preferred to those of alcoholE; using ecstasy is more 
convenient than using alcoholL; ease of use in comparison to 
other drugsO)
NNO NN, NN, NNE; NNL
Enhance energy and dancing
(help you to... keep going on a night out with friends, stay 
awakeD; to stay up longer, to dance/be more activeH; enable 
partying all night an makes the fun and excitement of the 
night last longerL; staying awake, enhancing dancing, dance 
energyM; stimulationP; dancingT)
91%, 72%D; 39%, 57%H; NNL; 
NN, NN, 60%M; NNP; 59%TB
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Enhance mood 
(to feel good)
(for funA; make yourself feel better when down or 
depressed, help you feel elated or euphoricD; enhance 
moodL; hedonistic pleasure, for a laugh, loved up feelingM; 
positive effects on mood, desire to have funO; a desire to feel 
goodP; funT)
NNA; NN, NNO 48%, 78%D; NNL; NN, 56%, 
NNM; 47%P; 42%T
Enhance other substances' effects
(improve the effects of other substances, help ease the after 
effect of other substancesB)
27%, 8%B
Enhance sex
(enhance feelings when having sexD; to enjoy sex moreH; 
increased sexual please, feeling more emotionally connected 
to partners during sexO; enhance sexT; prolong erection, 
enhance sexual sensations and arousal, unusual/exciting 
sexual activityV)
62%D; 22%H; NN, NNO; 29%T; 
10%, 23%, 21%V
Enhance social interaction
(help you to... enjoy the company of friends, feel more 
confident or more able to talk to peopleD; affirmation of 
friendships, ecstasy facilitates particular social activitiesE; I am 
more open with people, I am more confidentI; enhancing 
socialising, for socialising/confidence, to pull/have sex, 
opennessM; affiliation, being together with other peopleP; 
sociableT; facilitate sexual encounterV)
63%, 42%D; NN, NNE; NN, 65%, 
20%, NNM; NN, 71%P; 53%T; 
12%V
3%, 2%I
Enhance/change sensory perception
(help make something you do less boring, enhance an activity 
such as listening to musicD; sensory sensationsE; to alter 
perspectiveM; to produce altered states of consciousness, 
creative, to enjoy musicT)
36%, 80%D; NNE; 47%M; 70%, 
29%, 56%T
Experienced no or unpleasant ecstasy effects
(ecstasy experience does not live up to expectationsE; not 
feeling any effect of the ingested ecstasy pillsL; did not feel it 
the first timeU)
11%U NNE; NNL
Experienced very pleasant effects
(ecstasy experience is particularly goodL; liked what it did for 
me, thought subsequent experiences would be same/better 
than firstU)
93%, 89%U NNL
Fear of health risks
(worrying about... dying from ecstasy, risk of brain damageF)
1%, 1%F
Feeling safe about ecstasy contents and ecstasy use setting
(being certain about what is ingested and that an organisation 
of knowledgeable volunteers is presentG)
19%G 51%G
Help lose weight
(help you to lose weightD)
7%D
Help you to concentrate, work, or study
(help you to concentrate or to work or studyD)
3%D
Intoxication, losing inhibitions
(just get really stoned or intoxicated, help you to lose 
inhibitionsD; loss of inhibitionsE; just to get high/enjoy 
oneselfH; to lose it (being uninhibited)M; desire for an altered 
state of mind ("desire to get screwed up")O)
NNO 68%, 50%D; NNE; 91%H; 31%M
Table 2: Reasons and reported frequencies in each included study for starting ecstasy use, using ecstasy, using more ecstasy, and not ceasing ecstasy use. (Continued)B
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Noticed mood/affective/cognitive changes in oneself
(feeling depressed a few days after useF)
1%F
Other's bad experience/death/mood/affective/cognitive 
changes
(knowing someone who has had a bad experience on 
ecstasyF)
1%F
Own bad experience
(having a bad experience on ecstasyF)
1%F;
Positive effects outweigh negative effects
(positive effects seem to outweigh risks; positive effects from 
use outweigh the negative effectsE; ecstasy use feels too 
good despite worries about depressionK)
NNE NNE; NNK
Presence of opportunity
(ravesT)
58%T
Recreation/relaxation/stop worrying
(recreational purposesA; help you to... relax, stop worrying 
about a problemD; a time out from the normal routine and 
stress of daily lifeK; being at a major dance event, relax or 
unwindL; boredom, to switch off/relax, to escape problems/
worries/out of boredomM; boredom, desire to escapeO; 
relaxation, to party, to have a good time, coping with 
problems, as a distractionP)
NNA; NN, NNO 30%, 33%D; NNK; NN, NNL; 
NN, 69%, 32%, 21%M; NN, 57%, 
62%, 11%, 14%P
Self-medication
(enables socially anxious individuals and/or those with low 
self-esteem and confidence to fit in with others and have a 
good time, provides temporary relief from depressive 
symptomsO; insecurityP; personal 'psychotherapy', group 
'psychotherapy'T)
NN, NNO 6%P; 42%, 24%T
Social influence 
(friends use ecstasy)
(most of my friends take itI; being with friends who take the 
drug, desire to continue interacting with an ecstasy-using 
group of peersL; because mates take it, peer-group 
behavioursM; wanted to be accepted by friendsU)
20%M; 8%U 6%I; NNL; NNM NNL
Spirituality
(spiritual, close to natureT)
21%, 23%T
Note: superscripted letters denote studies as listed in Table 1, NN = no numbers (frequency or percentage) reported
Table 2: Reasons and reported frequencies in each included study for starting ecstasy use, using ecstasy, using more ecstasy, and not ceasing ecstasy use. (Continued)B
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Table 3: Reasons and reported frequencies in each included study for not starting ecstasy use, using less ecstasy, or ceasing ecstasy use.
Reason categories 
(reasons as reported in original papers in parentheses)
Not starting ecstasy Using less ecstasy Ceasing ecstasy use*
Addiction, fear of becoming dependent
(fear of addictionB, feeling dependent on ecstasyC, addiction/
toleranceO, addictionP)
0%B 16%C NNO; 36.3%P
Availability, price, quality of ecstasy
(financial reasons, high price of ecstasyA; financial costB; financial 
difficultiesC; knowing that a pill does not contain MDMA, 
monetary factors, quality factorsE; ecstasy quality... decreased, 
increasedF; perceived drop in ecstasy quality, money is a problemI; 
money problems, MDMA qualityJ; availability of ecstasyM; moneyO)
NNA; 2%B;5 7 % C; NN, NN, NNE; 34%, 10%F; 34%I; NNM NN, NNA *; 34%I; 1.4, 6.3J *; NNO
Changing life circumstances 
(moving in or out of a certain lifestyle)
(having decided not to do drugs anymoreA; changes in life 
circumstancesE; I'm getting older, if I was spending less time at 
clubs, if I was spending less time at pubs, if I was spending less 
time at partiesI; stopped clubbingJ; growing out of the sceneL; loss 
of interestO; moving onS)
NNE; 12%I; NNL;N N A *; 30%, 12%, 7%I; 5.1J *; NNO; 16%S
Lack of curiosity
(uninterested in the effects, unfamiliarity with the drug and/or its 
effectsB)
18%, 2%B
Decreased drug effects (e.g. tolerance) or decreased appreciation 
of drug effects 
(e.g. getting bored by effects)
(needing to take more tablets than used toF; I'm not getting the 
same rush as I used to getI; bored of the drug's effectsM)
9%F; 18%I; NNM
Ecstasy is overrated
(ecstasy is boring or overratedA; not every ecstasy experience is 
necessarily as good as the lastL)
NNL 25%A *
Experienced no effects or unpleasant effects
(experience was unpleasant, found the experience boringA; not 
enjoying drugJ; intensity of first experience was overwhelming and 
not worth the trouble of continuing to useK; ecstasy did nothing 
to meP)
25%, 41%A 5.6J *; NNK; 44%P
Fear of ecstasy's effects
(fear of the effectsB)
43%B
Lack of opportunity
(having had no opportunity to take ecstasyA; lack of opportunityB)
NNA; 10%B
Legal consequences
(external circumstances (legal)E; getting a criminal recordI; 
criminal recordJ; fear of legal consequencesO)
7%E; 10%I; 1.2J *; NNO
Minimising ecstasy comedown
(avoiding the ecstasy comedownQ)
56%QB
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Minimising health risks or fear of health risks
(wariness regarding the effects of ecstasy, health reasonsA; fear of 
physical harm, fear of psychological harmB; physical health effects, 
psychological problemsC; potential health risks, minimise the 
potential for negative or adverse outcomesE; worrying about... 
dying from ecstasy use, risk of brain damageF; fears about... long-
term effects on mental health, long-term effects on physical 
health, short-term effects on mental health, short-term effects on 
physical healthI; long-term mental health, short-term mental 
healthJ; avoid potential risksK; health concernsO; fear of damage to 
healthP; avoiding ecstasy-related negative side-effects, avoiding 
brain damage or neurotoxicityQ; negative effectsS)
NNA; 33%, 0%B 45%, 39%C; NN, NNE; 15%, 25%F; NN, NNK; 
71%, 58%Q
NNA *; 67%, 46%, 17%, 13%I; 5.8, 4.5J *; NNO; 
62%P; 14%S
Noticed mood/affective/cognitive changes in oneself
(external circumstances (medical)E; feeling depressed a few days 
after useF; finding it was doing my head in, it takes it out of you 
physically, I get depressed, I have some memory loss, it takes 
longer to come down, I have not been feeling healthy, it makes me 
less tolerant to othersI; depressed, paranoia, anxiety, memory, 
concentration, physical health worries, impulsive behaviour, 
sleeping worries, angry, eating worriesJ; depressionM)
27F; 30%, 17%, 13%, 13%, 12%, 6%I; NNM 7%E; 50%I; 5.6, 5.4, 5.3, 5.1, 4.9, 4.3, 3.3, 3.1, 
3.0, 2.9J *
Observation of others using ecstasy
(seen the effect on othersB; observation of others using ecstasyO)
16%B NNO
Other's bad experience/mood/affective/cognitive changes/death
(knowing someone who had a bad experience on ecstasyF; seeing 
someone have a bad experience on MDMA, knowing someone 
who... died as a result of taking MDMA, became mentally ill, 
became physically illI; other's bad experience, other mentally illJ; 
other's bad experiencesM)
11%F; NNM 31%, 19%, 17%, 14%I; 2.9, 2.2J *
Own bad experience
(having a bad experience on ecstasyF; personally having a bad 
experience on MDMAI; bad experienceJ; own bad experienceM; 
problems caused by ecstasyN; negative personal experiencesO)
22%F; NNM 25%I; 3.4J *; 60%N; NNO
Responsibilities (interference with or increase/decrease in) or 
relationship problems
(occupational problems, to improve quality of life, relationship 
problemsC; social factorsE; it places strains on my job/studies, I 
have more responsibilities, if I thought it... was negatively 
influencing my work/study, might affect my jobI; work affectedJ; 
fear of reduced efficiencyP)
28%, 17%C; NNE; 19.6%, 11.3%I NNA *; 37%C; 18%, 16%I; 4.7J *; 75%P
Social influence (friends quit using ecstasy)
(peer influenceB; if friends were giving up, most of my friends have 
given it upI; friends quitJ; peer-group behaviours, being with 
people who don't use (many) drugsM)
7%B 9%I; NN, NNM 22%I; 1.8J *
Social influence from relatives
(pressure from relatives, relatives finding out I was taking MDMAI; 
relatives finding out, relatives' pressureJ)
2%, 2%I; 2.0, 1.7J *
Note: superscripted letters denote studies as listed in Table 1, * Study A reports reasons to not use ecstasy for 1–3 time users, and study J reports scores to indicate relevance of each reason on 
a 10-point scale, reported by ex-users, NN = no numbers (frequency or percentage) reported
Table 3: Reasons and reported frequencies in each included study for not starting ecstasy use, using less ecstasy, or ceasing ecstasy use. (Continued)B
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Table 4: Overview of the reason categories in which one or several reasons were reported for each behaviour
Reason categories Starting ecstasy 
use
Using ecstasy Using more 
ecstasy
Not ceasing 
ecstasy use
Not starting 
ecstasy
Using less ecstasy Ceasing ecstasy 
use
Addiction, fear of becoming 
dependent
8 ±±
Availability/price/quality of 
ecstasy
N±± - + ±
Changing life circumstances 
(moving in or out of a certain 
lifestyle)
±± ±
Curiosity 
(or lack of curiosity)
N ±
Decreased drug effects or 
decreased appreciation of drug 
effects
±±
Denying or forgetting negative 
effects
N
Desire to be on the same level 
as friends (i.e. to be similarly 
intoxicated)
N+
Ecstasy is overrated N±
Ease of administration N N
Enhance energy and dancing +
Enhance mood (to feel good) N +
Enhance other substances' 
effects
±
Enhance sex +
Enhance social interaction + -
Enhance/change sensory 
perception
+
Experienced no or unpleasant 
ecstasy effects
±N ± ±
Experienced very pleasant 
effects
+N
Fear of ecstasy's effects ±
Feeling safe about ecstasy 
contents and ecstasy use setting
N+
Help lose weight -
Help you to concentrate, work, 
or study
-
Intoxication, losing inhibitions N +
Legal consequences ±
Minimising ecstasy comedown +B
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Minimising health risks or fear of 
health risks
±++
Noticed mood/affective/
cognitive changes in oneself
±+
Observation of others using 
ecstasy
±N
Other's bad experience/mood/
affective/cognitive changes/death
±±
Own bad experience ±+
Positive effects outweigh 
negative effects
NN
Presence or lack of opportunity + ±
Recreation/relaxation/stop 
worrying
N+
Responsibilities or relationship 
problems
±+
Self-medication ±
Social influence (friends use 
ecstasy or quit using ecstasy)
±-N- -±
Social influence from relatives -
Spirituality +
Note: + denotes highly relevant categories; ± denotes moderately relevant categories; -denotes minimally relevant categories; N denotes that no relevance information was available; 8 denotes 
irrelevant reasons.
Table 4: Overview of the reason categories in which one or several reasons were reported for each behaviour (Continued)BMC Public Health 2009, 9:230 http://www.biomedcentral.com/1471-2458/9/230
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drawn except that reasons for related but different behav-
iours differ; nothing can be said about the degree to which
they differ. This conclusion does, however, imply that
determinant configurations (i.e. relative relevance of each
of the determinants of a behaviour) of related but differ-
ent behaviours differ as well.
Thus, there is a need to find out whether and to what
degree determinant configurations for ecstasy use-related
behaviours differ, ideally by comparing one or more
behaviours (e.g. trying out ecstasy, using ecstasy and ceas-
ing use) in one study. If these determinant structures do
indeed differ, interventions should target different deter-
minants depending on the specific behaviour that is tar-
geted. In addition, future studies should measure the
beliefs underlying the reasons for each behaviour. Ideally,
for each behaviour, beliefs potentially underlying all rea-
sons that have been studied (i.e. that have been marked in
Table 4) are quantitatively examined. That way, over time,
a clear picture will emerge as to the relative relevance of
each of these reasons.
Just after the current review was completed, two new man-
uscripts were published that also addressed reasons to
refrain from trying out ecstasy [50,51]. Vervaeke, Ben-
schop and Korf conducted a factor analysis and found
support for three factors: fear of the effects, rationality,
and lack of opportunity [50]. Rosenberg, Baylen, Murray,
Phillips, Tisak, Versland and Pristas used a different
method and distinguished eight factors: harm to thinking,
school, work, or athletic performance; ecstasy use is con-
trary to values/self-image; fear of failing a drug-test; fear of
effects on body; difficulty with acquiring ecstasy; fear of
dangerous outcomes; no enjoyment expected from
ecstasy; and fear of loss of control. Most reasons underly-
ing these factors reflect reasons from the earlier studies
that were included in this review, but additional reasons
to refrain from starting ecstasy use are also reported:
uncertainty about pill contents, medical reasons, no
access to ecstasy, already using another substance, and not
using on principle [in [50]], and against religion, fear of
damage to reputation, want to be a role model, don't
know where to get it, and fear of losing control [in [51]].
Especially interesting are the different factor structures
revealed by these two studies. This may be attributed to
their different methodologies of constructing the factors,
or to the different locales (Dutch versus American).
Conclusion
The results of this review provide a clear agenda for the
research needed to develop evidence-based interventions
addressing ecstasy use. Worth noting in this respect is that
many studies reported overlapping reasons, both within
and between studies. For example, it is unclear whether,
and if so, to what degree, the reasons "help enjoy the com-
pany of friends", "enhance socialising", and "being
together with other people" reflect similar determinants.
Ideally, a number of largely orthogonal beliefs can be
identified [by studies such as [50] and [51]], the relevance
of each of which can then be established for each behav-
iour. As multiple theoretical frameworks seem to apply to
ecstasy use [8], it seems advisable for future studies to
include variables specified by different theories so that it
can be determined whether and how the relevant beliefs
underlie these variables.
Finally, the combination of this study and the meta-anal-
ysis [8] has important implications. First, by virtue of their
strict quantitative approach, meta-analyses provide only a
very narrow view into the literature, excluding many stud-
ies that may provide valuable pointers for future research.
By considering these excluded studies, qualitative reviews
remain very valuable tools in synthesising the state of the
literature. Second, conclusions from such qualitative
reviews need to be quantitatively verified. As was also the
case in the current review, results from qualitative research
may not be corroborated by quantitative data. Thus, a bal-
anced synthesis of the state of the art requires both meta-
analytical and qualitative reviews.
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